Retour
Akeso Inc (AKESF) Gagner
Graphique du cours de l'action AKESF
AKESF Gagner
Akeso Inc
$14.55
0%
$0
À partir d'aujourd'hui :Mar 24, 15:01:29 GMT-4
Statistiques clés
Clôture préc.
$14.55
Prix d'ouverture
$14.73
Plage de la journée
$14.55 - $14.73
Plage de 52 semaines
$7.53 - $23.15
Volume
700
Volume moyen
1.5K
Rendement en dividend
--
BPA (TTM)
-0.14
Capitalisation boursière
$13.4B
Qu’est-ce que AKESO INC. ?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.